In the News
The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.
Published: August 15, 2019
Author: Megan Garlapow, PhD
Survivors of lymphoma my require individualized supportive care. Although a nurse-led lymphoma survivorship model did not provide clinically significant data, participants in the intervention group reported ... More >>.
Published: August 05, 2019
Mount Sinai researchers have developed a way to use immunotherapy drugs against treatment-resistant non-Hodgkin's lymphomas for the first time by combining them with stem cell transplantation, an approach th ... More >>.
Published: August 01, 2019
Around 22,000 people will be diagnosed this year in the U.S. with acute myeloid leukemia (AML), the second most common type of leukemia diagnosed in adults and children, and the most aggressive of the leukem ... More >>.
Published: July 19, 2019
Author: Susan Moench, PhD, PA-C
Patients with a subtype of non-Hodgkin lymphoma (NHL) associated with an infectious etiology may be at increased risk of developing particular second solid tumor malignancies also linked to specific types of ... More >>.
Published: July 17, 2019
Author: Christina Bennett, MS
A retrospective cohort study found that surveillance imaging for patients with follicular lymphoma (FL) did not improve their survival outcomes after first relapse, aligning with the results of a prior study ... More >>.
Published: July 01, 2019
More than 60 years ago, British physician Denis Parsons Burkitt and his associates achieved one of the signal successes in cancer medicine when they cured children in sub-Saharan Africa with a form of lympho ... More >>.
Published: June 17, 2019
On May 15, 2019, the Food and Drug Administration (FDA) approved venetoclax (Venclexta) in combination with obinutuzumab (Gazyva) for the initial treatment of adults with chronic lymphocytic leukemia (CLL) o ... More >>.
Published: June 04, 2019
Results of a Phase II clinical trial conducted at The University of Texas MD Anderson Cancer Center revealed that combination targeted therapy, consisting of rituximab, lenalidomide and ibrutinib (RLI), had ... More >>.
Published: June 01, 2019
In patients with chronic lymphocytic leukemia (CLL), the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Fa ... More >>.
Published: May 10, 2019
Precision medicine centers on giving the right treatment to the right patient at the right time based on their genetic information and other characteristics. We are beginning to crack the code to apply preci ... More >>.